Skip to content

Study · Not a test of the peptide alone · 1993

1 result

How profilin promotes actin filament assembly in the presence of thymosin beta 4.

Pantaloni D, Carlier MF

Cell1 Dec 1993Cited by 428 (Europe PMC)

PMID8252614 (opens in a new tab)DOI10.1016/0092-8674(93)90544-z (opens in a new tab)PepBankPUB-08252614
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Mechanism

    In a cell-free system with thymosin beta‑4, low amounts of profilin promoted extensive actin assembly from the pool of actin-thymosin beta‑4 complex.

    In plain wordsIn lab tests, with thymosin beta‑4 present, small amounts of profilin made actin assemble into filaments from the thymosin beta‑4-actin pool.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseActin assembly with profilin in presence of Tb4
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.